BlackRock Increases Stake in MaxCyte, Inc.

MaxCyte (MXCT) has released an update.

MaxCyte, Inc. has reported a major change in holdings, with BlackRock, Inc. now possessing a combined total of 9.72% of voting rights after crossing the notification threshold on September 25, 2024. The acquisition involved both direct voting rights and financial instruments, resulting in a total of 10,223,882 voting rights held by BlackRock, Inc. This shift represents an increase from the previous notification where BlackRock held a combined 9.75% of the voting rights in MaxCyte.

For further insights into MXCT stock, check out TipRanks’ Stock Analysis page.